ADTX Stock Analysis: Buy, Sell, or Hold?
ADTX - Aditxt, Inc. Common Stock
$0.07
-0.02 (-20.67%)
▼
5d:
-42.71%
30d:
-85.06%
90d:
-90.32%
WAIT
LOW Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 21, 2026
5d
Get Alerted When ADTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
4 traders called ADTX this week
67% bullish • 2 bearish
67% bullish • 2 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ADTX is down 42.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ADTX is down 42.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ADTX is currently trading at $0.07, which is considered oversold relative to its 30-day fair value range of $0.13 to $0.45.
Technical Outlook: Technically, ADTX is in a downtrend. Immediate support is located at $0.06, while resistance sits at $0.21. Short-term momentum is weak, with the stock down 20.7% recently.
Market Sentiment: ADTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $61.00 (+91217.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ADTX is in a downtrend. Immediate support is located at $0.06, while resistance sits at $0.21. Short-term momentum is weak, with the stock down 20.7% recently.
Market Sentiment: ADTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $61.00 (+91217.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.13 -
$0.45
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-20.7%)
- BULLISH: Trading 91217.4% below Wall St target ($61.00)
- WARNING: Recommendation downgraded due to -42.7% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.13 -
$0.45
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.06
Resistance Level
$0.21
Current Trend
Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.35
Wall Street Target
$61.00
(+91217.4%)
Revenue Growth (YoY)
-86.6%
Share & Embed Analysis
Last updated: May 14, 2026 7:33 PM ET
Data refreshes hourly during market hours. Next update: 8:33 PM
Data refreshes hourly during market hours. Next update: 8:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADTX showing a specific setup today?
Insider Activity (6 Months)
1
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Financial Lp Hrt
SELL
11982 shares
2026-04-22
Financial Lp Hrt
BUY
72912 shares
2026-04-21
Brian Michael Brady
SELL
2025-12-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 65 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$26 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 54 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$130 | 52 HOLD |
